Autolus Therapeutics PLC (NASDAQ:AUTL)
| 1.92 BATS BZX Real-Time Price As of 11:46am ET |  +0.06 / +3.23%Today’s Change | 1.60 Today|||52-Week Range 4.73 | +1.05% Year-to-Date |
Institutional investors purchased a net $80.6 million shares of AUTL during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 62.25% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
| Other institutional | 60.47% |
| Mutual fund holders | 1.78% |
| Individual stakeholders | -- |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/31/2022 | DEEP TRACK CAPITAL LP Bought 15.0 Million shares of Autolus Therapeutics PLC |
| 12/31/2022 | SYNCONA INVESTMENT MANAGEMENT LT... Bought 14.0 Million shares of Autolus Therapeutics PLC |
| 12/31/2022 | ARMISTICE CAPITAL LLC Bought 10.2 Million shares of Autolus Therapeutics PLC |
Top 10 Owners of Autolus Therapeutics PLC
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Syncona Investment Management Ltd... | 12.34% | 21,346,829 | 41,412,848 | +14,000,000 | +190.56% |
| Deep Track Capital LP | 8.67% | 15,000,000 | 29,100,000 | +15,000,000 | -- |
| Qatar Investment Authority (Inves... | 8.67% | 15,000,000 | 29,100,000 | +15,000,000 | -- |
| Armistice Capital LLC | 5.91% | 10,224,000 | 19,834,560 | +10,224,000 | -- |
| Tetragon Financial Management LP | 5.47% | 9,461,883 | 18,356,053 | +9,461,883 | -- |
| TFG Asset Management UK LLP | 4.80% | 8,300,000 | 16,102,000 | +5,260,619 | +173.08% |
| Nantahala Capital Management LLC | 4.50% | 7,782,018 | 15,097,115 | +2,566,230 | +49.20% |
| Odey Asset Management LLP | 1.44% | 2,499,400 | 4,848,836 | +2,499,400 | -- |
| Citadel Advisors LLC | 1.03% | 1,777,068 | 3,447,512 | +675,952 | +61.39% |
| J.O. Hambro Capital Management Lt... | 1.00% | 1,733,391 | 3,362,779 | +362,634 | +26.46% |
Top 10 Mutual Funds Holding Autolus Therapeutics PLC
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| iShares Biotechnology ETF | 0.51% | 877,150 | 1,701,671 | -7,667 | -0.87% |
| American Funds Small Cap World Fu... | 0.36% | 625,000 | 1,212,500 | 0 | 0.00% |
| Crown Sigma UCITS Plc - LGT Crown... | 0.32% | 550,000 | 1,067,000 | +550,000 | -- |
| Regnan UFI - Regnan Global Equity... | 0.24% | 414,972 | 805,046 | -91,054 | -17.99% |
| Erste Stock Biotec | 0.11% | 195,000 | 378,300 | +16,641 | +9.33% |
| Harbor Disruptive Innovation Fund | 0.08% | 139,445 | 270,523 | -3,116 | -2.19% |
| JOHCM Regnan Global Equity Impact... | 0.04% | 70,554 | 136,875 | +32,070 | +83.33% |
| Fidelity Nasdaq Composite Index F... | 0.03% | 53,736 | 104,248 | 0 | 0.00% |
| SPDR S&P International Small Cap ... | 0.03% | 53,560 | 103,906 | 0 | 0.00% |
| Heptagon Fund Plc - Kettle Hill U... | 0.02% | 38,611 | 74,905 | +385 | +1.01% |